OZK enters the back half of April with an unusual mix: shorts covering at a meaningful pace while options traders remain more defensively positioned than at almost any point in the past year.
The most striking development is the speed of the short unwind. Short interest peaked at roughly 17.3% of the free float on April 13 — an elevated reading that coincided with broader market stress — and has since fallen sharply to 14.6% as of April 28. That is a drop of more than two and a half percentage points in just two weeks, suggesting shorts who piled in during the tariff-driven volatility have been taking profit or cutting exposure after the stock held up better than feared around Q1 earnings. On the week alone, short interest fell 5.5%. The ORTEX short score, at 65.9, remains elevated in an absolute sense — placing OZK firmly in the more-shorted tier of regional banks — but the score has been drifting lower for eight consecutive sessions, from a recent peak of 66.9 on April 20 down to 65.9 on April 28. The directional signal is clear: positioning is unwinding, not building.
The lending market tells a complementary story. Borrow availability is comfortable, not stressed — the current cost to borrow is a modest 0.47%, up roughly 16% from a week ago but down 6% over the past month, meaning the recent uptick is a blip against a broader easing trend. The borrow market is nowhere near the tightest levels OZK has seen over the past year (peak availability utilization touched 30% in the 52-week window), and current conditions give shorts plenty of room to maneuver if they want to re-enter. Options positioning paints a more guarded picture. The put/call ratio is running at 1.83, just below its 52-week high of 1.87, and about one standard deviation above its 20-day average of 1.70. That is not a panic reading, but it is a consistently defensive one — the PCR has been above 1.80 every session since April 20. Put demand has climbed even as short sellers have been reducing, a divergence worth watching.
The Street is broadly neutral on OZK, with the mean analyst price target at $52.33 against a current price of $48.30 — implying around 8% upside, but the analyst community has been in target-cutting mode for months. The most recent action from a bellwether firm came from UBS in early April, which assumed coverage at Neutral with a $48 target, essentially pricing the stock at fair value right here. Morgan Stanley lifted its Equal-Weight target to $61 back in March, but the more recent drift has been from Wells Fargo raising slightly to $50 and a cluster of January cuts from TD Cowen, Morgan Stanley, Stephens, and Piper Sandler, all trimming but maintaining positive ratings. The net message: the Street sees limited near-term upside and is selectively more cautious on valuation, without outright turning bearish. The PE multiple has expanded about 0.6 points over the past month to just under 8x — cheap in absolute terms, a reflection of the macro credit risk premium still embedded in regional bank valuations. The price-to-book at 0.83x similarly remains well below one, leaving the stock in deep-value territory if asset quality holds.
The bull and bear cases crystallize around that credit risk question. Bulls point to Q1 results that showed resilience — mid-single-digit loan growth, a 12.1% increase in tangible book value per share, and ROA of 1.75% — with management guiding for stronger loan growth acceleration into 2027. The bear case centres on what happens if economic growth disappoints: higher charge-offs, margin compression from rate cuts, and concentrated exposure in commercial real estate lending that could amplify losses if the cycle turns. The Q1 earnings reaction on April 21 was modestly negative — shares fell about 3.5% on the day — though the five-day move was a more contained -1.9%, suggesting the market absorbed the print and moved on rather than marking the stock down aggressively.
On the institutional side, the major passive holders (Vanguard at 10.1%, BlackRock at 9.2%, State Street at 6.0%) all added shares in Q1 2026, as did American Century, which increased its position by over 300,000 shares. The founder and CEO George Gleason holds 5.4% of the company with no change reported in the most recent filing — a stabilising anchor for sentiment. The one director purchase on record — an independent board member buying $131,640 worth of shares at $43.88 in March — is modest in size but directionally positive at a time when the stock was near its recent lows.
The next catalyst is the Q2 earnings call scheduled for July 23. Between now and then, the key variable to track is whether the options market's persistent put demand reflects genuine credit concern or simply a structural hedge on a name that remains one of the more shorted regional banks in the US.
See the live data behind this article on ORTEX.
Open OZK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
